Skip to main content
  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Research Articles

Biochemical Characterization of AMG 102: A Neutralizing, Fully Human Monoclonal Antibody to Human and Nonhuman Primate Hepatocyte Growth Factor

Teresa L. Burgess, Jan Sun, Susanne Meyer, Trace S. Tsuruda, Jilin Sun, Gary Elliott, Qing Chen, Mitsuru Haniu, Will F. Barron, Todd Juan, Ke Zhang, Angela Coxon and Richard L. Kendall
Teresa L. Burgess
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan Sun
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susanne Meyer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Trace S. Tsuruda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jilin Sun
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gary Elliott
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qing Chen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mitsuru Haniu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Will F. Barron
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Todd Juan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ke Zhang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Angela Coxon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard L. Kendall
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1535-7163.MCT-09-0824 Published February 2010
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: February 2010 to January 2021

AbstractFull-text HTMLPDF
Total330025931902

Cited By

Article Information

Volume 9, Issue 2, pp. 400-409

DOI 
https://doi.org/10.1158/1535-7163.MCT-09-0824
PubMed 
20124448

Published By 
American Association for Cancer Research
Print ISSN 
1535-7163
Online ISSN 
1538-8514
History 
  • Received September 2, 2009
  • Revision received November 6, 2009
  • Accepted December 6, 2009
  • Published first February 2, 2010.

Article Versions

  • Previous version (February 2, 2010 - 08:57).
  • You are viewing the most recent version of this article.
Copyright & Usage 
©2010 American Association for Cancer Research.

Author Information

  1. Teresa L. Burgess1,
  2. Jan Sun1,
  3. Susanne Meyer5,
  4. Trace S. Tsuruda2,
  5. Jilin Sun3,
  6. Gary Elliott4,
  7. Qing Chen2,
  8. Mitsuru Haniu2,
  9. Will F. Barron2,
  10. Todd Juan2,
  11. Ke Zhang6,
  12. Angela Coxon1 and
  13. Richard L. Kendall1
  1. Authors' Affiliations: 1Oncology Research, 2Protein Science, 3Clinical Immunology, and 4High Throughput Screening-Molecular Pharmacology, Amgen Inc., Thousand Oaks, California; 5Department of Molecular, Cellular and Developmental Biology, University of California, Santa Barbara, California; and 6Laboratory of Cancer Biology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland
  1. Corresponding Author:
    Teresa L. Burgess, Amgen Inc., One Amgen Center Drive, M/S 14-1-B, Thousand Oaks, CA 91320-1799. Phone: 805-447-2493; Fax: 1-805-375-8368. E-mail: tburgess{at}amgen.com
View Full Text
PreviousNext
Back to top
Molecular Cancer Therapeutics: 9 (2)
February 2010
Volume 9, Issue 2
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Cancer Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Biochemical Characterization of AMG 102: A Neutralizing, Fully Human Monoclonal Antibody to Human and Nonhuman Primate Hepatocyte Growth Factor
(Your Name) has forwarded a page to you from Molecular Cancer Therapeutics
(Your Name) thought you would be interested in this article in Molecular Cancer Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Biochemical Characterization of AMG 102: A Neutralizing, Fully Human Monoclonal Antibody to Human and Nonhuman Primate Hepatocyte Growth Factor
Teresa L. Burgess, Jan Sun, Susanne Meyer, Trace S. Tsuruda, Jilin Sun, Gary Elliott, Qing Chen, Mitsuru Haniu, Will F. Barron, Todd Juan, Ke Zhang, Angela Coxon and Richard L. Kendall
Mol Cancer Ther February 1 2010 (9) (2) 400-409; DOI: 10.1158/1535-7163.MCT-09-0824

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Biochemical Characterization of AMG 102: A Neutralizing, Fully Human Monoclonal Antibody to Human and Nonhuman Primate Hepatocyte Growth Factor
Teresa L. Burgess, Jan Sun, Susanne Meyer, Trace S. Tsuruda, Jilin Sun, Gary Elliott, Qing Chen, Mitsuru Haniu, Will F. Barron, Todd Juan, Ke Zhang, Angela Coxon and Richard L. Kendall
Mol Cancer Ther February 1 2010 (9) (2) 400-409; DOI: 10.1158/1535-7163.MCT-09-0824
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • A Novel TRAIL-Based Technology for Tumor Therapy
  • Trastuzumab Targeting of Metastatic Esophageal Cancer
  • Mcl-1 Determines the Fate of KSP-Inhibited Cells
Show more Research Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCT

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

Advertisement